This bill mandates the Agency for Health Care Administration to seek federal approval within 30 days of the act becoming law to provide Medicaid coverage for continuous glucose monitors and related supplies as durable medical equipment. It specifies that licensed durable medical equipment providers must be reimbursed for these items, with claims submitted through the Medicare Healthcare Common Procedure Coding System, and clarifies that the agency cannot require the use of a National Drug Code number for these claims. Additionally, the bill allows for the possibility of providing further coverage for continuous glucose monitors as a Medicaid pharmacy benefit.

The agency is required to implement these changes once the necessary federal approval is obtained. The bill emphasizes the importance of timely action to ensure that Medicaid recipients have access to essential medical equipment that can aid in the management of diabetes. The act will take effect immediately upon becoming law.